AIGLEI / 2024
AI & Future Economy / 08 May 2024
From prediction to proof: where AI changes drug discovery
Better molecular hypotheses can accelerate research, while validation remains the decisive investment.
Read the analysis ↗GLEI / INSIGHTS
Insights
Exploring the science, economics and human potential of longevity. Independent perspectives for a healthier, more equitable future.
IndustrialGLEI / 2022
Industrial Economics / 19 January 2022
Longevity capital needs a milestone vocabulary
Financing capacity and clinical validation answer different questions about the sector.
Read the analysis ↗HealthspanGLEI / 2020
Healthspan Equity / 17 December 2020
A longer life should also be a more accessible life
Functional ability connects scientific progress with the everyday conditions of healthy ageing.
Read the analysis ↗BioactiveGLEI / 2017
Bioactive Materials / 17 July 2017
Bioactive materials need an identity-to-outcome evidence chain
Matsutake research begins with material characterization; claims require evidence about the actual formulation.
Read the analysis ↗